Tenax Therapeutics (TENX) Interest & Investment Income (2022 - 2026)
Tenax Therapeutics recorded quarterly Interest & Investment Income of $861000.0 in Q1 2026, down 6.21% quarter-over-quarter from $918000.0 in Q4 2025, and down 7.42% year-over-year from $930000.0 in Q1 2025.
Tenax Therapeutics' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $861000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 7.42% year-over-year to $861000.0; the TTM figure through Mar 2026 stood at $3.8 million (up 37.56% YoY), while the FY2025 annual figure was $3.8 million, up 99.53% from the prior year.
- Interest & Investment Income came in at $861000.0 for Q1 2026 at Tenax Therapeutics, down from $918000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.0 million in Q4 2024 to a low of -$150741.0 in Q3 2023.
- A 5-year average of $571850.6 and a median of $850877.0 in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 221898.41% in 2023 and retreated 25.64% in 2024, its largest moves.
- Tenax Therapeutics' Interest & Investment Income stood at $63.0 in 2022, then surged by 1350498.41% to $850877.0 in 2023, then gained by 20.7% to $1.0 million in 2024, then slipped by 10.61% to $918000.0 in 2025, then declined by 6.21% to $861000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $861000.0, $918000.0, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | 861,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 861,000.00 |
| Dec 31, 2025 | 918,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 954,000.00 |
| Mar 31, 2025 | 930,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 665,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 118,000.00 |
| Dec 31, 2023 | 850,877.00 |
| Sep 30, 2023 | -150,741.00 |
| Jun 30, 2023 | 139,859.00 |
| Jun 30, 2022 | 63.00 |